Related Experiment Video
Updated: Jun 24, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Proteinuria after kidney transplantation: its relation to hepatitis C virus and graft outcome
Alaa Sabry1, Rashad Hassan, Ihab Mahmoud
1Department of Nephrology, Mansoura Urology and Nephrology Center, Mansoura University, Mansoura, Egypt. asabry20@yahoo.com
Insights
Hepatitis C Virus (HCV) infection is common in Egyptian kidney transplant recipients. While HCV doesn't increase proteinuria, nephrotic-range proteinuria significantly worsens graft survival and increases chronic allograft nephropathy.
Area of Science:
- Nephrology
- Virology
- Transplantation Immunology
Background:
- Chronic Hepatitis C Virus (HCV) infection is linked to kidney disease in native and transplanted kidneys.
- Egyptian kidney transplant patients exhibit a high prevalence of HCV infection.
Purpose of the Study:
- To evaluate HCV infection at transplantation and its association with proteinuria.
- To determine the impact of proteinuria on long-term graft survival in kidney transplant recipients.
Main Methods:
- Retrospective study of 273 Egyptian end-stage renal disease patients transplanted between 1993-1996.
- Assay for anti-HCV antibodies at transplantation.
- Evaluation of post-transplantation proteinuria and its effect on graft survival.
Main Results:
- 61.9% of kidney recipients were positive for anti-HCV antibodies.
- Proteinuria incidence (33% vs. 32%) and quantity (median 0.6 g/d vs. 0.4 g/d) were similar between HCV-positive and negative groups.
- Nephrotic-range proteinuria correlated with worse graft survival (P < .001) and higher chronic allograft nephropathy (P = .03).
Conclusions:
- High prevalence of HCV infection in end-stage renal disease patients awaiting kidney transplantation.
- HCV infection does not increase the incidence or quantity of proteinuria.
- Nephrotic-range proteinuria is an independent predictor of chronic allograft nephropathy and poorer graft outcomes.
Introduction:
Chronic Hepatitis C Virus (HCV) infection has been associated with glomerular disease in native and transplanted kidneys. We evaluated the presence of HCV infection at the time of transplantation and occurrence of proteinuria in Egyptian kidney transplant patients and their link with graft survival.
Materials And Methods:
This retrospective study was done on 273 patients with end-stage renal disease transplanted in Mansoura Urology and Nephrology Center Between 1993 and 1996. Their sera were routinely assayed for anti-HCV antibodies at the time of transplantation. The relationship between the HCV and the development of posttransplantation proteinuria was evaluated, along with the possible effects of proteinuria on long-term graft survival.
Results:
A total of 169 kidney recipients (61.9%) were positive for anti-HCV antibodies. The mean durations of post-transplant follow-ups were 87.73 +/- 26.79 months (range, 19 to 123 months) and 84.29 +/- 28.55 months (range, 11 to 123 months) for the patients with and without anti-HCV antibodies, respectively. The patients in these groups were comparable regarding the incidence of proteinuria (33% and 32%, respectively) and its quantity (median, 0.6 g/d and 0.4 g/d, respectively). Irrespective of the HCV infection, patients with nephrotic-range proteinuria showed a worse graft survival (P < .001) and a higher frequency of chronic allograft nephropathy (P = .03) compared with nonproteinuric patients.
Conclusions:
There is a high prevalence of HCV infection in our patients with end-stage renal disease awaiting kidney transplantation. The incidence and quantity of proteinuria do not increase by HCV infection, and nephrotic-range proteinuria is independently associated with chronic allograft nephropathy and a poorer graft outcome.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury III: Clinical Manifestations
Nephrotic Syndrome I : Introduction
Diabetic Nephropathy